Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by CareDx, Inc.

< Previous 1 2 3 Next >
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports First Quarter 2025 Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Report First Quarter 2025 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Launches Two Expanded Indications for AlloSure Testing Services
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces Fourth Quarter and Full Year 2024 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Report Fourth Quarter and Full Year 2024 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Preliminary Financial Results for Third Quarter 2024
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Appoints Jing Huang Chief Data and AI Officer
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Host Investor Day on October 15, 2024
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap Testing
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Second Quarter 2024 Results and Increases Revenue Guidance
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Report Second Quarter 2024 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients
From CareDx, Inc.
Via Business Wire
Tickers CDNA
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.